Pandemic (H1N1) 2009 and HIV Infection
To the Editor: In the United States during spring and fall of 2009, pandemic (H1N1) 2009 infl uenza A virus resulted in 2 major outbreaks of disease. Initial reports identifi ed immunosuppression, including HIV infection, as a risk factor for the development of severe infl uenza (1) (2) (3) (4) (5) . Subsequent reports did not confi rm this association, but the number of HIV-infected patients in these studies was small (6, 7 (6) (7) (8) (9) . Most of the 23 patients described here had mild disease and were treated as outpatients. Only 3 required ICU admission, and 2 of these died. Although the mortality rate reported here is higher than that reported in other studies, our sample size was relatively small, and the patients who died had additional risk factors for poor outcomes. To the Editor: Triple-reassortant swine infl uenza viruses (SIVs), which contain genes from human, swine, and avian infl uenza A viruses, have been enzootic among swine herds in the United States since the late 1990s (1). Although uncommon, occasional transmission of triple-reassortant SIVs from swine to humans has occurred (2-4). Before April 2009, only limited, nonsustained humanto-human transmission of SIVs had been reported (5-7). Although an animal source for pandemic (H1N1) 2009 virus has yet to be identifi ed, the pandemic strain resulted from the reassortment of 2 different lineages of SIV (8) .
On July 28, 2009, a 12-yearold Kansas boy sought treatment for fever, cough, and sore throat. Results of an infl uenza rapid antigen test were positive, and a specimen was sent to the Kansas Department of Health and Environment for further testing. Realtime reverse transcription PCR (rRT-PCR) testing determined the virus contained the surface hemagglutinin (HA) gene of infl uenza A (H3) and the internal nucleoprotein gene common to all triple-reassortant SIVs (9). The specimen was sent to the Centers for Disease Control and Prevention (Atlanta, GA, USA) on August 3 and identifi ed as swine-origin infl uenza virus A (H3N2) by rRT-PCR and sequence analysis.
The patient reported that during July 23-25, 2009, he touched healthyappearing swine multiple times while attending a county fair. The boy received a standard treatment course of oseltamivir and recovered completely. None of his 3 household contacts attended the fair, and none reported signs or symptoms of illness in the weeks afterward.
The Kansas Department of Health and Environment and the local health department collaborated with the county extension offi ce to identify and interview swine exhibitors at the county fair, focusing on infl uenza symptoms among exhibitors and household contacts during the week before and after the fair. Twenty-seven (79%) of 34 exhibitors participated in the survey; none reported signs or symptoms of infl uenza-like illness, defi ned as fever (temperature >100°F) accompanied by either cough or sore throat. Two household contacts of separate exhibitors each reported a low-grade fever (<100°F) and sore throat in the week after the fair. Both touched swine while attending the fair. Both visited a physician's offi ce; neither was tested for infl uenza; and symptoms of both resolved without treatment. The veterinarian overseeing the swine barn reported no signs of respiratory illness among the swine during the fair. Most swine exhibited were slaughtered at the fair's conclusion.
On August 7, the Kansas Animal Health Department collected nasal swab specimens and blood samples from 13 swine belonging to 7 exhibitors. All samples were delivered to the Kansas State Veterinary Diagnostic Laboratory for analysis by infl uenza matrix rRT-PCR and virus isolation on nasal swab samples and hemagglutination inhibition (HI) assays against classical swine infl uenza virus (H1N1) (A/swine/Iowa/73) and the prototype swine infl uenza virus (H3N2) (A/swine/Texas/98) on serum samples. In addition, the infl uenza virus (H3N2) "county fair" isolate, A/Kansas/13/2009 (H3N2), was sent from the Centers for Disease Control and Prevention, amplifi ed, and used to develop a second HI assay that included the original swine serum samples as well as paired convalescent-phase samples from 3 of the swine (Table) .
Infl uenza matrix RT-PCR and virus isolation on nasal swab samples were negative. HI assays demonstrated little or no antibody against the infl uenza (H1N1) indicator virus and low-level antibody reaction against the prototype swine infl uenza virus (H3N2). However, HI titers against the "county fair" infl uenza virus (H3N2) showed consistently elevated titers, which suggested that the animals might have been exposed to the virus 2 weeks earlier, during the time of the fair. The swine may have cleared the virus by the time the nasal swabs were collected, but without positive RT-PCR or virus isolation results, the situation remain inconclusive.
We compared the HA gene segment of A/Kansas/13/2009 (H3N2) with recent animal and human infl uenza (H3N2) viruses by using the neighbor-joining method, and it clustered with the HA from recent triple-reassortant SIV (H3N2) isolates (online Appendix Figure, 
